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Active targeting of nanoparticles to tumours can be achieved by conjugation with speciﬁc
antibodies. Speciﬁc active targeting of the HER2 receptor is demonstrated in vitro and in vivo
with a subcutaneous MCF-7 breast cancer mouse model with trastuzumab-functionalized
gold nanoparticles. The number of attached antibodies per nanoparticle was precisely
controlled in a way that each nanoparticle was conjugated with either exactly one or exactly
two antibodies. As expected, in vitro we found a moderate increase in targeting efﬁciency of
nanoparticles with two instead of just one antibody attached per nanoparticle. However, the
in vivo data demonstrate that best effect is obtained for nanoparticles with only exactly one
antibody. There is indication that this is based on a size-related effect. These results highlight
the importance of precisely controlling the ligand density on the nanoparticle surface for
optimizing active targeting, and that less antibodies can exhibit more effect.
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I
n the last 10 years, the exponential growth of nanotechnology
has led to new opportunities in biology and medicine, from
the development of highly sensitive biosensors for the
detection of molecular interactions to novel medical diagnostic
tools, from therapeutic applications in oncology to drug delivery
systems, and from cellular therapy to tissue engineering1–3.
Colloidal nanoparticles (NPs), including metal, magnetic and
semiconductor NPs, are a versatile tool to integrate nanotech-
nology and biology, provided that they are complemented with a
proper surface functionalization. To this aim, several strategies
have been proposed in the attempt to optimize the surface
modiﬁcation of NPs with organic and biological targeting ligands
to improve the NP afﬁnity towards biological receptors4.
However, recent developments have pointed out that a few
requirements should be taken into account in designing
bio-targeted NPs, including tight irreversible (or reversible)
binding, and control on density and orientation5–8. While
several studies have been carried out to achieve a control on
linkage stability9, as on ligand orientation and density10, besides
some examples11,12, a general strategy to introduce a discrete
precisely controlled number of targeting biomolecules to each NP
is still largely missing. Importantly, this makes it difﬁcult to
provide direct evidence on the relationship between the extent of
NP functionalization and the targeting efﬁciency of the NP as a
selective diagnostic tool or a drug delivery system. In this work,
we propose a straightforward method to introduce a discrete
number of biomolecules (here in the form of antibodies) on
NPs for biomedical applications. We developed a nanostructured
probe consisting of colloidal polymer-coated Au NPs function-
alized on their surface with a deﬁned discrete number of
trastuzumab (Tz) molecules. This monoclonal antibody reco-
gnizes the HER2 receptor (human epidermal growth factor
receptor 2), which is overexpressed in about 25–30% of breast
tumours, and its clinical use has signiﬁcantly changed the natural
history of HER2-positive breast cancer (BC). By recognizing the
HER2 receptor, Tz blocks its downstream signalling activity13 and
interferes with the PI3K survival pathway14, therefore causing cell
cycle arrest and inhibition of cancer proliferation. Moreover, Tz is
able to activate the antibody-dependent cellular cytotoxicity by
recruitment of natural killer cells15. Therefore, Tz nanoconjugates
are expected to combine a focused targeting action with a
therapeutic effect on HER2-positive tumours. In this work we
report a method to synthesize NPs with a precisely controlled
number of attached antibodies, that is, exactly one or exactly two
Tz antibodies per NP, with the goal of probing the dependence of
the antibody density on the NP surface on in vitro and in vivo
targeting efﬁciency. Unexpectedly, we ﬁnd that despite an
intuitive belief that in vivo targeting efﬁciency should rise on
increasing the amount of antibodies per NP, the tumour homing
and protracted therapeutic efﬁcacy are best achieved with just one
antibody attached per NP. As NPs with nonspeciﬁc IgG anti-
bodies were used as control, our data also allowed to distinguish
between active, that is, Tz-mediated binding, versus passive
targeting, that is, tumour enrichment of NPs due to enhanced
permeation and retention (EPR) effect. Data show that only in
case of one Tz antibody per NP, but not in case of two Tz
antibodies per NP, the effect of active targeting could be observed.
Results
NP preparation and characterization. The 5 nm core diameter
Au NPs were synthesized according to the Brust–Schiffrin
protocol16 in organic phase and transferred to aqueous solution
by overcoating them with an amphiphilic polymer17. For purpose
of visualization, organic dyes (ﬂuorescein isothiocyanate (FITC)
or Alexa Fluor 660 (AF660)) were optionally integrated into the
polymer shell18. The resulting NPs had a core diameter
of dc¼ 4.8±1.3 nm (s.d.; Supplementary Fig. 1), a hydro-
dynamic diameter of dh¼ 8.28±0.63 nm and a zeta potential of
z¼ –23.7±1.8mV in water (Supplementary Table 1). Colloidal
properties, toxicity and biodistribution of these NPs have been
characterized in detail and we refer to previous publications19,20
(Supplementary Figs 1 and 2). Polyethylene glycol (bis-amino-
PEG, MwE10 kDa) was linked covalently to the surface of
the NPs by standard bioconjugate chemistry and the resulting
NP-PEG conjugates were fractionated by agarose gel electro-
phoresis. This allowed us to extract NPs with exactly one or
exactly two PEG molecules attached per NP (5NP-1P and 5NP-
2P, respectively)21. For linkage of Tz antibody to the terminal
amino group of PEG, the carbohydrate unit of the vicinal rings in
the Fc region of the Tz antibodies was mildly oxidized with
sodium periodate. This led to reactive aldehyde groups, resulting
in an imine bond, which was in situ reduced giving a stable
secondary amine bridge22. As the saccharide moiety is placed in
the Fc portion of the antibody, this conjugation strategy was well
suited for our study because (1) all the Tz molecules were
positioned with the same arrangement on the NP surface and (2)
the Fab binding site was presented in an optimal orientation for
receptor binding on each NP (Fig. 1).
Conjugation was veriﬁed by observing the increase in
hydrodynamic diameters with dynamic light scattering (DLS),
as by dot blot analysis (Supplementary Table 1 and Supple-
mentary Figs 3 and 4). The difference in ligand density (one
versus two antibodies per NP) was investigated by quantiﬁcation
of protein corona formation around the NPs (without ﬂuores-
cence label in their polymer shell) by incubating them with
FITC-labelled bovine serum albumin (BSA). As expected, the
surface functionalization with Tz decreased the extent of protein
adsorption (as quantiﬁed by measurements of FITC ﬂuorescence
intensity (FI)), which in the case of NPs with only one Tz
antibody attached per NP (that is, 5NP-1Tz), was twofold higher
than in the case of two Tz antibodies attached per NP (that is,
5NP-2Tz). This result conﬁrmed a double-accessible surface area
due to the different extent of functionalization (Fig. 2 and cf. the
Methods section for experimental details and Supplementary
Figs 5 and 6). The stability of the NPs in serum was evaluated up
to 96 h by DLS analysis. We found that both kinds of NPs
maintained the original hydrodynamic size (Supplementary
Table 2). Besides the direct detection of double ﬂuorescence
emission in NPs with two attached Tz (5NP-2Tz) as compared
with NPs with one Tz attached (5NP-1Tz; Fig. 1b), we attempted
to achieve conﬁrmation on the ﬁnal number of antibody mole-
cules per NP. Unfortunately, both Fourier transform infrared
spectroscopy analysis and transmission electron microscopy
(TEM)-negative staining did not provide conclusive results due
to strong interference from the organic polymer coating.
However, robust previous evidence with different molecular
structures or even larger objects such as multiple NPs corroborate
our conclusion21,23. Fluorescence of the NPs with attached Tz
was not affected by incubation in human plasma (Supplementary
Tables 3 and 4).
In vitro targeting and cell viability. The targeting efﬁciency and
selectivity of 5NP-1Tz and 5NP-2Tz towards HER2 were ﬁrst
assessed using MDA-MB 468, MCF-7 and BT474 cell lines, which
showed basal, moderate or high expression of HER2, respectively
(Fig. 3 and Supplementary Fig. 7). Cells were treated with dif-
ferent concentrations of NP-Tz conjugates with FITC label in the
polymer shell of the NPs (13 and 65 nM NP concentration) at
37 C for 1 h, to simulate in vitro physiological interaction
between cells and NPs. The amount of NP-Tz conjugates attached
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to cells was then assessed by ﬂow cytometry (Fig. 3a). NPs
conjugated to one or two generic anti-rabbit IgG molecules, or
only to one or two PEG molecules per NP, were used as negative
controls, while untreated cells were used to set the singlet gate
and the positive region in which cells were identiﬁed as decorated
with NPs. In MCF-7 and BT474, the percentage of cells in
the positive region in the case of NP-Tz conjugates was at least
10-fold higher than the one in the controls, demonstrating the
speciﬁcity of the NP-cell targeting via Tz-HER2 recognition.
Moreover, the percentage of cell labelling in these cell lines was
almost 100% even at the lowest concentration, suggesting that
13 nM NP-Tz conjugates had already saturated the signal. The
NP-Tz conjugates displayed a very low and dose-dependent
percentage of labelled MDA-MB 468 cells, in accordance to the
poor HER2 expression. The recognition mediated by Tz main-
tained its speciﬁcity, as suggested by statistical signiﬁcance in
comparison with controls (Po0.05, Student’s t-test). In addition,
the analysis performed with MDA-MB 468 cells pointed out that
the immobilization of two Tz molecules per NP did not seem to
confer any advantage in cell recognition in vitro. Indeed,
excluding aggregated cells bridged by individual 5NP-2Tz by
means of singlet gate data analysis we did not observe any
increase in the percentage of labelled cells in samples treated with
5NP-2Tz in comparison with 5NP-1Tz. However, these data
could not exclude that a NP with two Tz antibodies attached is
instead capable of bridging two HER2 receptors on the same cell,
resulting in a more pronounced therapeutic effect as suggested by
viability and cell death assays (Fig. 3b,c).
MDA-MB 468 and BT474 cells were excluded from next
experiments due to their too low and too high HER2 expression,
respectively. MCF-7 cells were instead selected to develop the
in vivo model because their moderate HER2 expression could
allow us to better appreciate differences in tumour recognition
and accumulation of 5NP-1Tz versus 5NP-2Tz. The decrease
in MCF-7 cell viability due to the treatment with NPs was
statistically signiﬁcant at all concentrations and times tested, and
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Figure 2 | Functionalisation of 5 nm Au NPs with a discrete number of ligands. (a) Image of an agarose gel with 5NP, 5NP-1P, 5NP-2P and 5NP-3P
conjugates. (b) Fluorescence intensity of 5NP-1Tz, 5NP-2Tz and 5NP-3Tz, whereby each Tz molecule is labelled with one AF660 ﬂuorophore.
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was dose- and time-dependent (Fig. 3b). We also observed
differences between samples treated with 5NP-1Tz or 5NP-2Tz,
which suggests a correlation between the amount of antibody
immobilized on the NP and the toxicity of the nanoconjugate.
However, since both 13 and 65 nM of free Tz were not effective
under the tested conditions, our ﬁndings suggest a synergistic
contribution between NPs and Tz to cellular toxicity. Cell death
induced by NPs in comparison with untreated cells was
statistically signiﬁcant after 72 h of incubation. As expected, a
better antibody-mediated antitumour activity of NPs with two
antibodies per NP was observed. This is probably due to the
availability of a double amount of antibody molecules, although
free Tz does not seem to be effective under the same conditions
(Fig. 3c). However, any possible contribution to signiﬁcant
cytotoxic effects derived from Au NPs without ligands attached
was ruled out by previous data obtained at the same concentra-
tions used in this work19.
The cellular uptake of 5NP-1Tz and 5NP-2Tz was studied by
confocal microscopy (Fig. 4). Images are consistent with an early-
stage partial compartmentalization of 5NP-1Tz in endosomes
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Figure 3 | In vitro assays. (a) Binding assay with BC cells. MCF-7, BT474 and MDA-MB 468 cells were incubated at 37 C for 1 h with 13 and 65 nM FITC-
labelled NPs functionalized with 5NP-1Tz and 5NP-2Tz, and then processed with ﬂow cytometry, in which labelling of cells with NPs was detected. FITC-
labelled NPs functionalized with generic rabbit IgG (IgG) or only with PEG were used as speciﬁcity controls. Untreated cells were used to create viable cells
and singlet gates, and to set the positive region assigned to labelled cells. (b) Viability of cells treated with NPs. MCF-7 cells were treated with 13 and
65 nM of NPs or Tz for up to 72 h. Viability was tested by measuring the conversion of MTT into formazan. Reported values are the mean of six
replicates±s.e., normalized on cell proliferation of untreated MCF-7 cells (control), respectively. *Po0.01, 5NP-1Tz or 5NP-2Tz versus control; yPo0.01,
5NP-1Tz versus 5NP-2Tz antibodies (Student’s t-test). (c) Cell death assay on incubation with NPs. MCF-7 cells were treated with 13 and 65 nM of NPs for
24, 48 and 72 h. Untreated cells and Tz-treated cells (13 and 65 nM) were used as control. Cell death was assessed based on the exposure of Annexin V,
evaluated by ﬂow cytometry. Live cells were used to set the region of positivity. Reported values are the mean of three replicates±s.e. *Po0.01, 5NP-1Tz or
5NP-2Tz versus control; yPo0.01; yyPo0.0005, 5NP-1Tz versus 5NP-2Tz (Student’s t-test). CTRL, control.
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only after 4 h, while 5NP-2Tz exhibited detectable co-localization
already after 1 h. This result suggested that 5NP-2Tz are
internalized in HER2þ cells faster than 5NP-1Tz. Within this
time intervals, no co-localization with other organelles was
observed in both cases.
In vivo targeting and biodistribution. Two groups of Balb/c
nude mice, bearing a subcutaneous MCF-7 BC, were treated with
NP-Tz conjugates (18 pmol g 1 body weight). Labelling of anti-
bodies with AF660 dye proved to be more reliable than direct NP
labelling and was then preferred. NP-Tz conjugates were injected
in mice by the tail vein and their availability in plasma and
localization at the tumour was monitored 5, 24, 48 and 96 h after
injection. The quantiﬁcation of gold in plasma, obtained by indu-
ctively coupled plasma mass spectrometry (ICP-MS), revealed
that the blood half-life calculated for the monofunctionalized NPs
was not different from that of the bifunctionalized NPs
(Supplementary Table 5), and therefore the biodistribution and
the tumour homing of the nanoformulations was not affected by
their availability in plasma between 5 and 96 h after injection.
To detect the localization of the NPs into the xenografts,
epiﬂuorescence (Epf) images of anaesthetized supine mice were
obtained by an IVIS Lumina II imaging system. Figure 5a indi-
cated that the NP-Tz conjugates were able to target the HER2þ
tumours at 5 h post injection. A strong increase in tumour Epf
was observed after 24 h, which did not vary over the following
48 h. 5NP-2Tz showed twofold higher intrinsic FI compared with
5NP-1Tz, due to the double number of labelled antibodies on
each NP. Therefore, the Epf average values of the region of
interest (ROI) on the Epf intensity of the two solutions was
normalized. Four mice per experimental condition were analysed.
Our results showed a twofold higher Epf normalized intensity at
the tumour when 5NP-1Tz were injected compared with
mice treated with 5NP-2Tz, surprisingly suggesting a stronger
propensity of conjugates with one versus two antibodies attached
to each NP to accumulate at HER2þ tumour (Fig. 5b). Confocal
microscopy analysis of tumour cryosections isolated between
5 and 96 h post injection showed that both types of NP-Tz
conjugates came into contact with the BC cells to be then inter-
nalized (Fig. 6). However, while ﬂuorescence of 5NP-2Tz
completely decayed at 96 h post injection, the signal from
5NP-1Tz was still detectable in BC cells. TEM images of the same
samples (Fig. 7) provided evidence that both types of NP-Tz
conjugates were captured by the plasma membrane of BC cells
within the ﬁrst 5 h, and membrane invagination indicated binding
of the NPs to the target receptors activating the process of
internalization. As expected, both types of conjugates were then
directed to endosomes (24 and 48 h). However, only 5NP-2Tz
were found in lysosomes at 96 h post injection, where the
degradation of the ﬂuorescent protein material likely occurs
(Fig. 7), while 5NP-1Tz were still observed in endosomes.
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Figure 4 | Intracellular localization of 5NP-1Tz and 5NP-2Tz. Confocal microscopy images of MCF-7 cells, incubated for 1 or 4 h at 37 C with 65 nM of
%NP-1Tz or 5NP-2Tz (FITC ﬂuorescence in green). Early endosomes, lysosomes, Golgi and recycling endosomes were recognized, respectively, with the
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10mm. Pearson’s correlation coefﬁcients (P) have been calculated using the image J plugin JaCoP.
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The systemic biodistribution of the injected NP-Tz conjugates
was also investigated by analysing the Epf of mice bladder ROI at
5, 24, 48 and 96 h post injection. Supplementary Fig. 8 shows that
(at least the ﬂuorescence polymer part of) both types of
conjugates were eliminated by kidney excretion, with a higher
extent for 5NP-1Tz as compared with 5NP-2Tz, which is likely
due to the smaller size8,20. The maximal amount of NPs (or more
accurately of the ﬂuorescence polymer part of the NPs) inside the
bladder was recorded at 24 h post injection, and decreased over
the following hours. ICP-MS was used to quantify the amount of
gold from the NP-Tz conjugates in tumour, heart, liver, lungs,
kidneys and spleen dissected at different experimental times
(Supplementary Fig. 9). The results conﬁrmed a higher accumu-
lation of the monofunctionalized NPs in tumours as compared
with the bifunctionalized ones (Fig. 5). Moreover, only 5NP-1Tz
exhibited a progressive increase in gold content over time, while
the amount of 5NP-2Tz in the tumour reached a maximum at
24 h post injection and decreased over the following hours, to
remain almost undetectable at 96 h. Liver and spleen were the two
off-target organs mainly subjected to gold localization, while the
NP-Tz conjugates did not accumulate in kidneys, where the NPs
likely underwent ﬁltration to be rapidly excreted via the bladder.
Unlike tumours, the gold content of 5NP-1Tz in liver and spleen
decreased after 24 h, while an increasing trend over time was
observed for 5NP-2Tz up to 96 h. Hence, 5NP-1Tz as compared
with 5NP-2Tz seem to be preferable for tumour targeting in vivo,
as they accumulate in a larger amount at the malignant site where
they are subjected to a slower degrading process. Moreover,
monofunctionalized NPs undergo a more efﬁcient renal clearance
compared with the bifunctionalized ones, with a reduced accu-
mulation in off-target organs at longer times of exposure.
The importance of active molecular recognition in targeting
MCF-7 cells in vivo was assessed. In detail, the accumulation of
the two types of HER2-targeted NP-Tz conjugates in the tumour
mass of mice was compared with tumour distribution of the same
NPs functionalized with a nonspeciﬁc rabbit IgG antibody. From
the in vivo and ex vivo ﬂuorescence images of the tumours
exposed for 5 and 48 h to the targeted and non-targeted NPs
(Fig. 8), we derived Epf values that were normalized to the Epf
intensity of the different solutions. Normalization was achieved
by dividing the ﬂuorescence emission of an injectable solution of
5NP-2Tz at the same concentration of a solution of 5NP-1Tz by a
factor of 2. Figure 5c,d conﬁrmed the more efﬁcient tumour
targeting of 5NP-1Tz as compared with 5NP-2Tz in vivo,
suggesting a greater access of the monofunctionalized NPs to
BC cells. This is likely to be a size-related issue, as in fact, the
tumour Epf values of the mice treated with IgG-NP conjugates
with one IgG antibody per NP (5NP-1IgG), indicative of the
passive, that is, EPR contribution, were also higher than those
recorded in the mice exposed to conjugates with two IgG
antibodies per NP (5NP-2IgG) (Fig. 5c,d). As expected, the
Epf intensity of the tumours exposed to HER2-targeted
NPs signiﬁcantly increased after 48 h. Nevertheless, while no
signiﬁcant change in the Epf intensity was observed for
5NP-1IgG, an enhanced Epf signal was recorded for 5NP-2IgG,
comparable to that observed in mice treated with conjugate with
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Figure 5 | In vivo tumour targeting. Epf images of (a) mice bearing MCF-7 xenografts and (b) averaged Epf intensity of the tumour ROI are shown,
acquired 5, 24, 48 or 96 h after exposure to 5NP-1Tz and 5NP-2Tz labelled with AF660. The colour scales in a indicate ﬂuorescence expressed as radiant
efﬁciency ((p s 1 cm 2 sr 1) (mWcm 2) 1), where p s 1 cm 2 sr 1 is the number of photons per second that leave a square centimetre of tissue and
radiate into a solid angle of one steradian (sr). The scale extends from the following minimum–maximum values (left to right, top to bottom): 4.94 107–
6.03 107; 1.19 108–1.50 108; 8.45 107–1.01 108; and 1.30 108–1.80 108. In the control mouse no injection was performed. Averaged Epf
intensity of (c) tumour ROI and (d) isolated tumours are shown, acquired 5 or 48 h after exposure to non-functionalized 12 (12NP) or 20 nm (20NP) NPs,
or to 5NP-1Tz and 5NP-2Tz or 5NP-1IgG and 5NP-2IgG, labelled with AF660. In e, ﬂuorescence intensities (FIs) of tumour homogenates are displayed. Epf
and FI values were normalized to the FI of injected solution to keep into account the differences in intrinsic ﬂuorescence emission for each NP-antibody
conjugate. Mean value±s.e. of three different samples for each experimental condition are provided. *Po0.05, **Po0.01 and ***Po0.001 versus 5 h;
yPo0.01 and yyPo0.001 versus 5NP-1Tz (Student’s t-test). ND, non-detectable.
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two Tz per NP (Fig. 5c,d). The FI values of tumour homogenates,
normalized on the FI of the injected solution (Fig. 5e), highlighted
the higher accumulation in BC cells of 5NP-1IgG versus 5NP-
2IgG, as a result of a higher EPR effect. Also, the difference in the
tumour homing between both IgG-NP conjugates after 48 h post
injection was conﬁrmed. Therefore, the monofunctionalization of
Au NPs was the only way to discriminate between the active and
the passive tumour targeting at 48 h post injection. This was
possible because the EPR effect in the mice treated with
monofunctionalized NPs did not increase over time, as rather
occurred in the mice exposed to bifunctionalized NPs. The
exclusive role of the EPR effect on affecting the tumour targeting
of bi- versus monofunctionalized NPs in vivo was conﬁrmed by
the confocal analysis of tumour cryosections (Supplementary
Fig. 10), where no differences in the localization of the two types
of HER2-targeted NPs were observed. This could be explained in
terms of a smaller number of bifunctionalized NPs homing at the
tumour compared with mono-, although those NPs that can
reach the tumour tissue effectively bind to the HER-2 in MCF-7
cells. As expected, no interaction with the cells occurred in the
presence of nonspeciﬁc NPs functionalized with one or two IgGs
per NP (Supplementary Fig. 10).
5NP-1Tz 5NP-2Tz
5 h
24 h
48 h
96 h
Figure 6 | Fluorescence confocal microscopy of tumours. Confocal laser
scanning micrographs (single optical sections) of cryosections obtained
from MCF-7 tumours isolated 5, 24, 48 or 96 h after exposure to 5NP-1Tz
or 5NP-2Tz, labelled with AF660, and then counterstained with anti-
cytokeratin19 and DAPI for tumour cells and nuclei detection, respectively.
The confocal images of NPs (red) have been overlaid on the corresponding
images reporting nuclei (blue) and cells (green). The scale bar corresponds
to 10mm.
5 h
5NP-1Tz 5NP-2Tz
d
m
n
d
n
m
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48 h
96 h
Figure 7 | Transmission electron microscopy of tumours. TEM images of
MCF-7 tumours isolated 5, 24, 48 or 96 h after exposure to 5NP-1Tz or
5NP-2Tz. In the insert of each single ﬁgure, the corresponding higher
magniﬁcation image is reported. NPs are evidenced by arrows; d,
desmosome; n, nucleus; m, mitochondrion. The scale bars correspond to
100 nm.
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To establish whether the size of the NPs, besides the different
number of ligands, could affect tumour homing, we treated
MCF-7 tumour-bearing mice with AF660-labelled non-functio-
nalized Au NPs of 12 (12NP) or 20 nm (20NP) core diameter,
resembling the size of mono- and bifunctionalized NPs,
respectively (Supplementary Figs 11 and 12). We ﬁrst measured
the plasma half-life of these NPs by ICP-MS, resulting in values
signiﬁcantly lower than those of the HER2-targeted NPs
(Supplementary Table 4). This result was in accordance with
the surface charge of these non-PEGylated and non-targeted NPs,
which was expected to promote the formation of the protein
corona and the interactions with the immune system compo-
nents. The localization of 12NP and 20NP into the tumour
xenografts was then performed in vivo and ex vivo. We found that
the tumour homing of these NPs at 5 and 48 h post injection was
strongly affected by their low plasma availability, as demonstrated
by the total lack of a detectable Epf signal in supine mice (Fig. 5c
and Supplementary Fig. 13) and FI in tumour homogenates
(Fig. 5e), and by a very low Epf in dissected tumours (Fig. 5d and
Supplementary Fig. 13). The Epf of the tumours exposed to 12NP
was comparable to that observed with 20NP between 5 and 96 h
post injection (Supplementary Fig. 14). Therefore, we concluded
that the higher efﬁciency of NPs with one versus two antibodies
attached in accumulating in HER2þ tumours (Fig. 5a,b) is not
caused simply by the reduced size of the NPs, but rather the
number of surface ligands plays a crucial role. While the NP
stability experiments, which are shown in Supplementary Table 2,
demonstrate that there is no apparent desorption in vitro,
complete integrity in vivo cannot be warranted. However, we
could build on previous evidence that the polymer coating
remains predominantly anchored to the NP core in plasma,
although it is partly degradable in the liver20. In addition, due to
5 h
48 h
5 h
48 h
a
b
5NP-1Tz 5NP-IgG 5NP-2Tz 5NP-2IgG
Figure 8 | In vivo active targeting contribution. (a) Epf images of mice bearing MCF-7 xenografts and (b) isolated tumours, acquired 5 or 48 h after
exposure to 5NP-1Tz, 5NP-1IgG, 5NP-2Tz or 5NP-2IgG, labelled with AF660. The minima and maxima of the logarithmic colour scales are in
(p s 1 cm 2 sr 1) (mWcm 2) 1 (from left to right): (a) 5 h: 3.46 107–6.06  107; 3.46 107–6.06 107; 5.79 107–7.04 107; and 5.79 107–
7.04  107; (a) 48 h: 7.91 107–1.00 108; 3.46 107–6.06 107; 8.43 107–1.11 108; and 8.43 107–1.11 108; (b) 5NP-1Tz and 5NP-1IgG: 1.85 106–
8.23 106; (b) 5NP-2Tz and 5NP-2IgG: 3.79 106–1.43 107.
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the control 12NP and 20NP, and due to the control NPs with IgG,
we can conclude that the targeting effect is speciﬁc for Tz-bearing
NPs. The role of the PEG, which has been used as linker, has not
been investigated in this study. While there may be some loss in
targeting efﬁciency due to partial degradation, the effect of the
remaining intact NPs is still dominating.
Regulation of HER2 expression. To get insights into the ther-
apeutic effect of the as-characterized mono- and bifunctionalized
Au NPs on BC, we investigated their regulatory activity onto the
expression of HER2, the therapeutic target of Tz. Tumour-bearing
mice were injected with NP-Tz conjugates (calculated to have
18pmol per g body weight of Tz, both with 5NP-1Tz and
5NP-2Tz) or with a comparable amount of free Tz (18 pmol per g
body weight), labelled with the AF660 dye. We ﬁrst checked that
injected Tz was indeed able to target BC in the MCF-7-based
murine model, by assessing its accumulation at the tumour
site by measuring the ﬂuorescence from AF660 (Supplementary
Fig. 15). Next, mice treated with 5NP-1Tz and 5NP-2Tz,
respectively, were killed and dissected at 5, 24, 48 and 96h post
injection. Total HER2 expression in the tumour tissue homo-
genates from all mice was analysed by western blotting
(Supplementary Figs 16 and 17) and the percentage variation of
HER2 expression over time was calculated for each group of
mice. HER2 expression recorded at 5 h post injection was con-
sidered the baseline in each group of treatment and was normalized
to 100%. As shown in Fig. 9a, treatment of mice with Tz induced a
progressive decrease of HER2 protein expression at 24 and 48h,
while at 96h the decrease was no longer signiﬁcant when compared
with that recorded at 48h. Treatment with 5NP-2Tz led to
a signiﬁcant reduction of HER2 protein only at 24h, while
a tendency towards decrease was suggested at 48h; no additional
decrease occurred at 96h. Finally, the results obtained on treatment
with 5NP-1Tz indicated that no variation in the total HER2
expression occurred within the ﬁrst 24h, while a pronounced
decrease was detectable at 48h with a further obvious decrease at
96h post injection, thus indicating a sustained therapeutic effect
over time only with this formulation.
Given the claimed effect of Tz in triggering HER2 endocytosis,
with subsequent downregulation of HER2 protein at the plasma
membrane, we decided to speciﬁcally analyse the effect of Tz
conjugated to NPs and free Tz on the expression level of the
transmembrane pool of the receptor. We performed HER2
immunohistochemistry on tumour sections obtained from mice
treated with the three different formulations. An immunoscore of
HER2 expression from 0 to 3þ was assigned to each sample, as
reported in Fig. 9b. Control tissue had 2þ score. We observed
that at 5 h post injection, the HER2 immunoscore was
comparable to that recorded in controls both in tumours treated
with Tz and NP-Tz conjugates with 5NP-2Tz, while it decreased
to 1 in case of treatment with NP-Tz conjugates with 5NP-1Tz.
Over the following experimental times, no remarkable changes
were observed in HER2 membrane expression in response to
bifunctionalized NP-Tz conjugates. A decrease of the receptor
immunoscore was recorded in Tz-treated tumours only between
24 and 48 h, while a further drop of HER2 expression up to 96 h
occurred only in response to 5NP-1Tz. Selected immunohisto-
chemical images of tumours isolated at 96 h post injection
(Fig. 9c) clearly show that a sustained downregulation of HER2
expression in BC cell membrane is only evident in tumours
treated with 5NP-1Tz.
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Figure 9 | HER2 expression modulation. (a) Percentage variation of total HER2 expression in tumour homogenates and (b) immunoscore (from 0 to 3þ )
of HER2 transmembrane expression on tumour sections obtained from mice exposed to free Tz or 5NP-1Tz and 5NP-2Tz for 5, 24, 48 or 96 h post injection.
*Po0.05, **Po0.01 and ***Po0.001 calculated comparing two consecutive time points. (c) HER2 expression on tumour tissues at 96 h post injection. The
control corresponds to non-injected animals. Injection of Tz and of 5NP-2Tz showed intense and complete HER2 immunostaining on cellular membrane
(brown colour), while in case of injection of 5NP-1Tz only rare cells were HER2þ , with weak and incomplete cellular membrane staining ( 20). High-
magniﬁcation images of immunostaining are reported in insets (40). The scale bars in the upper left picture in c correspond to 100 or 10mm in low- or
high-magniﬁcation images, respectively, and apply for all other images.
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The intracellular trafﬁcking of HER2 on treatment with free or
nanoconjugated Tz was also conﬁrmed by immunoﬂuorescence
on tumour cryosections (Supplementary Fig. 18). It is intriguing
to note that a signiﬁcant trafﬁcking of the receptor in BC cells
occurred within the ﬁrst 5 h post injection only in tumours
treated with 5NP-1Tz, in line with the strong downregulation
observed by immunohistochemistry at 5 h (Fig. 9b). All three Tz
formulations altered HER2 membrane localization between 24
and 48 h post injection but, at 96 h, the HER2-associated
ﬂuorescence was restored on the plasma membrane of some
Tz- and 5NP-2Tz-treated cells, according to the immumohisto-
chemical images (Fig. 9c).
Discussion
Generally speaking one might assume that receptor-mediated
binding of ligand-modiﬁed NPs is improved by increasing the
number of ligands per NP. However, there are certain restrictions
to keep in mind. Concerning the NPs, in case of too high ligand
density, accessibility of ligand to bind to receptors may be
sterically hindered. In addition, higher ligand density may
increase the size of the NP and thus NP diffusion to the receptor
may be geometrically hindered in case of three-dimensional
tissues. Concerning the cells, the receptor density of the plasma
membrane is an important parameter. Only in case receptors can
be close enough together to allow for multiple ligand binding
from the ligands of one NP to several receptors, there may be an
added beneﬁt. Experimental quantiﬁcation however is not trivial.
This starts with the fact that determination of the number of
ligands per NP is not straightforward, and that typically there is a
large distribution of this number, that is, different NPs will have a
different number of ligands bound per NP. Second, one has to
distinguish between active and passive effects. Even without
speciﬁc targeting, there is enrichment of NPs in tumours due to
the EPR effect, which will overlay any active targeting effect.
In this work, we have developed a straightforward method for
the synthesis of colloidal NPs functionalized with a discrete
number of antibody molecules with a precise control on the
ligand density on each NP. This was applied for antibodies
speciﬁc to the target (Tz), and nonspeciﬁc antibodies (IgG) as
control to probe for passive targeting. As expected, in vitro
speciﬁc targeting was moderately increased for 5NP-2Tz versus
5NP-1Tz. Speciﬁcity could be demonstrated as NPs conjugated
with nonspeciﬁc IgG antibodies showed negligible binding to
cells. However, in vivo targeting was clearly improved for
5NP-1Tz versus 5NP-2Tz. Targeting was also less speciﬁc, as
also NPs conjugated with nonspeciﬁc IgG antibodies were
delivered to tumours, though at lower amounts. There is an
ongoing discussion in literature about the possible contribution of
active (that is, ligand–receptor-mediated) versus passive (that is,
EPR effect-mediated) targeting of tumours with NPs. While in
some studies clear contribution of active targeting is demon-
strated, in other studies effects seem to be based predominantly
on passive targeting24. Our results suggest that these discre-
pancies might be explained in terms of ligand density on the NP
surface. In case of low ligand densities (in our study one speciﬁc
antibody per each NP) contribution of active versus passive
targeting seems to be higher than in case of higher ligand
densities (in our study two speciﬁc antibodies per NP). We
propose the hypothesis that a combination of the EPR effect and
active targeting action is effective for 5NP-1Tz, in which the
active targeting contribution becomes more important in
proximity to the BC cells. In contrast, the EPR would be
dominant for 5NP-2Tz. While there is indication for this
hypothesis for our experimental conditions, the whole concept
would have to be corroborated for different systems with
controlled ligand density. Furthermore, our in vivo studies
suggest that long-term intratumour retention of 5NP-1Tz
contributes to a sustained therapeutic effect overtime as
compared with 5NP-2Tz and with Tz in standard HER2-
positive BC treatment. In this way, controlled conjugation of
NPs with a deﬁned ligand-NP stoichiometry, in particular
monofunctionalized NPs, may lead to more efﬁcient targeting
strategies.
Methods
Reagents and instrumentation. All chemicals were purchased from Sigma-
Aldrich (St Louis, MO) and used as received. Herceptin 150mg was acquired from
Roche. AFF660 dye was purchased from Life Technologies. Water was deionized
and ultraﬁltered by a Milli-Q apparatus from Millipore Corporation (Billerica, MA)
before use. DLS measurements were performed with a Malvern Zetasizer. Viscosity
and refractive index of pure water were used to characterize the solvent. NPs
were dispersed in the solvent and sonicated in a S15H Elmasonic apparatus
(Elma, Singen, Germany) before analysis. Final sample concentration used for
measurements was typically of 0.2 mM.
Synthesis of gold NPs. Five-nanometre gold NPs. Thiol-derivatized Au NPs were
prepared by the Brust–Schiffrin method16 with some modiﬁcations, as described in
detail in previous publications18. In brief, in a large separation funnel, a solution
containing 2.17 g of tetraoctylammonium bromide in 80ml of toluene was mixed
with a solution containing 300mg of tetrachloroauric acid in 25ml of Milli-Q
water. The organic phase was separated after several rounds of shaking and
transferred in a large bowl. A solution containing 0.334 g of sodium borohydride in
25ml Milli-Q water was added dropwise, resulting in a colour change to intense
red, indicating formation of NPs, and left under vigorous stirring for 1 h.
Afterwards, the resulting NP solution was washed with HCl and NaOH (25ml,
10mM) and Milli-Q water (25ml, four times) while removing the aqueous phase
after each step of washing. Finally, the resulting organic phase was left under
stirring overnight. The day after, 10ml of dodecanethiol was added and the
solution heated at reﬂuxed for 3 h at 65 C. The solution was cooled down to room
temperature, distributed in four separate vials, which were centrifuged at 550 g for
5min. Non-aggregated NP solution was separated from the precipitated NPs
and divided in six vials followed by dilution with methanol. Finally, the solutions
were centrifuged for 5min at 550 g, and the ﬁnal NPs were redispersed in
chloroform.
Twelve-nanometre gold NPs. Au NPs of ca. 12 nm core diameter were
synthesized as reported by Schulz et al.25. A volume of 144ml of Milli-Q water was
added to 250ml a round-bottomed ﬂask and heated up until boiling with a heating
plate. Then, sodium citrate (3.5ml; 60mM) and citric acid (1.5ml; 60mM) were
added to the ﬂask and kept under vigorous stirring for 30min. Then 100 ml of
ethylene diamine tetraacetic acid (EDTA, 30mM) was added, followed by 1ml of
25mM hydrogen tetrachloroaurate (III) aqueous solution. After ca. 1min the
colour of the mixture became wine red. After the NP formation, the heating was
stopped. When the temperature of the NP solution had lowered to 95 C, the ﬂask
was immersed in ice to stop the reaction. To determine the concentration, the
absorbance at 450 nm (extinction coefﬁcient e450¼ 1.09 108M–1 cm–1) was
used26.
Twenty-nanometre gold NPs. The 12 nm NPs were used as seed to NPs of 20 nm
diameter. To do that the protocol described by Bastus et al.27 was followed. Seeds
were heated up to 90 C, and then 1ml of HAuCl4 (25mM) was injected. The
solution was stirred for 30min, and this process was repeated twice, waiting 30min
after each gold addition. After the NP growth the ultraviolet–visible spectrum was
taken, and the concentration was determined using the absorbance at 450 nm
(extinction coefﬁcient e450¼ 5.41 108M–1 cm–1; extinction coefﬁcient values
extracted from Haiss et al.26.
Phase transfer of gold NPs to organic solvent. Prior to the transference to
organic solvent of the hydrophilic NPs, a ligand exchange with PEG is needed to
provide them with enough stability. Thus, this process has two steps, which are
explained below28.
PEGylation. The NP concentration was determined and the NPs were stabilized
by mPEG SH (CH3O-PEG-SH, Mw¼ 750Da (Rapp Polymere)) dissolved in
Milli-Q water. A volume of 10 ml of NaOH (1M) per ml of GNPs was added to
increase the pH to ca. 10, aiming to increase the reactivity of the thiol group. The
stoichiometric ratio of PEG molecules to the NPs was 5 105. The solution was
mixed by stirring overnight, although for the size of these NPs the exchange is
assumed to be complete within ca. 1 h (ref. 28).
Phase transfer. NPs were transferred to organic phase using a solution of
dodecylamine in chloroform (0.4M). Before this, PEGylated NPs were
concentrated via centrifugation to a ﬁnal volume of ca. 20ml. Thus, 20ml of
dodecylamine solution were used for each. By using a vigorous stirring the NPs
were transferred within 2 h. NPs were then cleaned via precipitation in, and washed
twice with clean chloroform28.
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Phase transfer of gold NPs to aqueous solution. The NPs suspended in
chloroform were transferred from organic to aqueous solution by wrapping an
amphiphilic polymer around their surface, resulting in monodisperse and highly
colloidally stable water-soluble NPs. An amphiphilic polymer, poly(isobutylene-
alt-maleic anhydride)-graft-dodecyl (PMA) was synthesized by linking dodecyla-
mine to 75% of the anhydride rings of polyisobutylene-alt-maleic anhydride
(average Mw B6,000 gmol–1, Sigma, #531278)18,29,30. A ﬂuorescent version of
PMA was synthesized by linking FITC via its amine end to 1% of the anhydride
rings of polyisobutylene-alt-maleic anhydride18. For the coating procedure an
aliquot of Vp¼ 101ml of cp¼ 0.5M PMA (concentration referring to the monomer
units of the polymer, as dissolved in chloroform) was added to Au NPs in
chloroform (cNP¼ 2.27 mM, VNP¼ 2ml). The amounts of reagents were calculated
based on the following equation: VP¼ (p  cNP VNP  deff2 Rp/area)/cP. Hereby cNP
and VNP are, respectively, the concentration and volume of the NP solution, cP and
VP are, respectively, the concentration and volume of the polymer solution,
deff2 is the effective diameter of one NP and Rp/area is the number of polymer
monomer units used per surface area. In this study Rp/area¼ 50 nm–2 was used
(the Rp/area value for 12NP and 20NP was 3,000 nm–2). The mixture was
homogenized and the solvent was then evaporated at reduced pressure. Sodium
borate buffer (pH 12, 10ml) was added obtaining a clean NP dispersion, which was
concentrated in Amicon tubes (100 kDa ﬁlter cutoff) by centrifuging at 550g.
Finally, the water-soluble polymer-coated NPs were washed twice diluting with
H2O in the same way and concentrated to a ﬁnal volume of 2ml).
The core diameter31 of the Au NPs was determined with TEM and was found to
be dc¼ 4.8±1.3 nm (Supplementary Fig. 1). The core diameter for 12NP and 20NP
was found to be dc¼ 13.4±0.9 and 19.5±1.5 nm, respectively (Supplementary
Fig. 11). We assumed in all the cases a thickness of the capping ligands of
lligand¼ 1.8±0.2 nm. Thus, estimated an effective diameter of deff¼ dcþ 2  lligand.
For 5NP deff¼ 8.4±1.7 nm (ref. 18).
The NP concentration was determined from the absorption at the maximum of
the plasmon peak A¼ l  cNP  e as measured in a cuvette with path length l and
assuming a molecular extinction coefﬁcient of the 5NPs of e¼ 8.63 106M–1 cm–1
(Supplementary Fig. 2). For 12NP and 20NP, the concentration was determined
using the same method, but considering the absorbance at 450 nm and the
following extinction coefﬁcients: e¼ 1.09 108 and 5.41 108M–1 cm–1,
respectively (Supplementary Fig. 12)26. Note that the appropriate metrics for
quantifying the amount of NPs are number concentrations (mol l–1] and not mass
concentrations (g l–1). One NP with two antibodies attached has a much higher
mass (considering the small diameter of the NPs) than one NP without any
antibody attached. In case both samples would be added with the same mass
concentration, there would be fewer NPs with two antibodies than NPs without
antibody in solution, due to the higher molecular weight in the NPs with two
antibodies attached per NP27. In the case of using solutions with the same number
concentration, however, in both solutions the same number of NPs is present. For
comparative studies to analyse the effect of NPs with different surface conjugation,
therefore number concentrations (M) should be applied.
Attachment of PEG to the surface of gold NPs. For the introduction of a discrete
number of functional groups, standard bioconjugation chemistry using 1-ethyl-
3-(3–dimethylaminopropyl)carbodiimide hydrochloride (EDC) was used exploit-
ing the carboxylic groups on the surface of polymer-coated Au NPs. The 10 kDa
diamine-PEG was selected as an optimal linker in-between the NPs and antibodies,
because of its high molecular weight, which allowed us to clearly distinguish the
distribution in discrete bands in the gel electrophoresis (Figs 1c and 2a). For all
functionalization experiments, stock solutions of polymer-coated Au NPs with the
concentration cNP¼ 6 mM in 50mM sodium borate buffer (pH 9.0) were prepared.
The same buffer was used to dissolve the diamine–PEG (NH2–PEG–NH2)
and EDC. For the coupling experiments, equal amounts of the NP solution
(cNP¼ 6 mM) and the PEG solution (cPEG¼ 3mM) were mixed and split into 20 ml
samples. In all samples the ratio of PEG molecules to NPs was kept constant
for all samples was cPEG/cNP¼ 500. To these, 10ml of an EDC solution of
appropriate concentration was added to achieve ratios of EDC molecules to NPs
of cEDC/cNP¼ 32,000, 16,000, 8,000 and so on. With this series, conditions were
established under which NPs with exactly two or with only one PEG molecule per
NP could be best synthesized21. The large excess of PEG molecules (that is,
NH2PEG–NH2) was chosen to prevent inter-particle crosslinking via the two
amino groups of PEG. The samples were mixed with a pipette and allowed to react
for at least 90min. For analysis of the conjugation gel electrophoresis was
applied21. Before running the gels, about 6 ml of gel-loading buffer containing
bromophenol blue and 30% glycerol was added to each sample. Two per cent
agarose gels were prepared with 0.5Tris/borate/EDTA buffer and run for
60–90min at 10V cm–1 (ref. 32). Analysis of these gels allowed for determining the
EDC/NP ratio with the highest yield of Au NPs with one or two PEG molecules
attached per NP (5NP-1P and 5NP-2P, respectively). For the preparation of a
larger amount of 5NP-1P and 5NP-2P, a larger amount of cNP¼ 6 mM polymer-
coated Au NPs (VNP¼ 450 ml) and consequently a large amounts of diamine–PEG
(cPEG¼ 3mM, VPEG¼ 50ml) and an appropriate concentration of EDC were
prepared in 50mM sodium borate buffer (pH 9.0). After reaction the sample was
loaded on a 2% agarose gel with a single big loading well for 90min to separate NPs
with a deﬁned number of attached PEG molecules10. Because of the attachment of
PEG, all reacted NPs showed a signiﬁcant shift on the gel as compared with the
bare NPs. In fact, the negatively charged Au NPs migrated towards the positive
pole becoming more retarded the larger the number of PEG molecules attached,
which permitted the isolation of 5NP-1P and 5NP-2P. The bands consisting of NPs
with exactly one or two attached PEG molecules (and thus exactly one or two free
amino groups at the PEG terminal pointing towards solution) were cut out and
immersed separately in 0.5 Tris/borate/EDTA buffer in a dialysis membrane
(molecular weight cutoff (MWCO) 3,500Da), and again an electric ﬁeld was
applied for 10min, 10 V cm–1. The buffer containing the extracted NPs was
collected and concentrated by centrifugation at 550g through 50 kDa Amicon
centrifuge ﬁlter tubes.
Conjugation of gold NPs with antibodies. The goal of this work was to set up a
strategy to control the number and orientation of monoclonal antibodies covalently
linked on the surface of individual NPs, giving rise to mono- and bi-Tz functio-
nalized NP conjugates (5NP-1Tz and 5NP-2Tz, respectively). Our approach was
characterized by the control of the number of functional binding sites (amino
groups of attached PEG) on each NP to favour the introduction of one single active
antibody (5NP-1Tz) or two antibodies (5NP-2Tz) covalently linked on the NP
surface to compare their targeting efﬁciency. Most general conjugation strategies
adopted for the immobilization of biological molecules on NPs are based on
nonspeciﬁc approaches, in which biological molecules are passively adsorbed on
the surface through electrostatic and hydrophobic interactions or covalently linked
exploiting nondirectional coupling reactions32,33. In such cases, it is complicated to
determine the number and orientation of targeting ligands on individual NPs.
Therefore, virtually no structure–activity relationship data are available in the
literature at present. In our approach, however, the attachment is directed and
covalent.
Herceptin (15mgml–1) was puriﬁed from excipients by dialysis using Slide-
A-lyzer cassette (MWCO 7,000Da) in phosphate-buffered saline (PBS, EuroClone,
pH 7.2) for 48 h at 4 C. The yield of Tz wasB30%. Puriﬁed Tz (1mg) was labelled
with Alexa Fluor 660 kit (Invitrogen). The labelled antibody solution was
reconstituted with 1ml of PBS (pH 7.2) at 4 C. The carbohydrate unit of the
vicinal rings in the Fc region of the Tz antibody were mildly oxidized with sodium
periodate resulting in reactive aldehyde groups4. NaIO4 (0.1mg; NaIO4/antibody in
a 1:10 weight ratio) dissolved in 100ml of PBS (pH 7.2) was added to the antibody
solution and incubated for 30min at 4 C under shaking (protected from light).
The antibody solution was transferred to an Amicon centrifuge ﬁlter tube (MWCO
10 kDa) and centrifuged for 10min at 4 C (3,000g). The concentrated antibody
solution was diluted to 1ml with PBS buffer (pH 7.2), loaded onto a PD-10 column
(pre-equilibrated with PBS, pH¼ 8) and centrifuged for 2min at 1,000g (ref. 22).
The diluted antibody solution was added to each solution of 1 or 2 diamine–
PEG functionalized NPs for 3 h at 4 C under shaking. NaCNBH3 (0.01ml) in PBS
buffer (pH 8, 16mM NaCNBH3) was added to each solution and incubated for
30min at room temperature. The reaction of the NH2 terminal groups on 5NP-1P
and 5NP-2P with the newly formed aldehyde functionalities in oxidized Tz resulted
in an imine linkage, which was in situ reduced giving a stable secondary amine
bridge21. To eliminate unreacted antibody, each functionalized NP solution was
cleaned by dialysis for 1 h, 2 h and overnight in a Float-A-Lyzer Spectra/Por G2
(MWCO 300 kDa) under stirring, at 4 C. As control, NP conjugates with generic
rabbit IgG molecules instead of Tz antibody were synthesized in the same way,
leading to 5NP-1IgG and 5NP-2IgG.
Characterization of antibody conjugation. Dynamic light scattering. Each
attached Tz or IgG molecule increases the overall size of a NP conjugate sig-
niﬁcantly, as, for example, human IgGs have intrinsic sizes of the same order of the
NP (typically 9 14 nm). Hence, the occurred conjugation reaction could be
monitored by DLS (Supplementary Fig. 3). DLS and laser Doppler anemometry
measurements were carried out in water and hydrodynamic diameters dh, given as
mean values from the number distribution, and z-potential values are summarized
in Supplementary Table 1. The s.d. values were obtained from several independent
measurements. Note that absolute size measurements with commercial DLS
set-ups as used here always have to be interpreted carefully.
Dot blot assay. Dot blotting was performed by ﬁltering proteins and/or NPs
onto polyvinylidene ﬂuoride membranes, utilizing a Manifold I dot blot apparatus
(GE Healthcare). Then each polyvinylidene ﬂuoride membrane was incubated in
blocking solution (5% skim milk in PBS, Tween 0.05%) for 1 h at room
temperature and probed for 1 h at room temperature in blocking solution using
goat anti-human-horseradish peroxidase antibody (Tebu-bio) at a 1:18,000
dilution. Membranes were rinsed three times in 0.05% Tween in PBS for
10min. Immunoreactive spots were revealed using ECL western blotting reagent
(GE Healthcare) and acquired with Odyssey Fc reader (LI-COR Biosciences).
Dot blot analysis conﬁrmed the occurrence of Tz binding to the PEG chains and
the maintenance of a proper protein folding and activity following conjugation
(Supplementary Fig. 4).
Fluorescence assay. Fluorescence analyses were performed to check the presence
of antibodies on the NP surface and afterwards to investigate the maximum
number of antibodies on each NP. In particular, we explored also the possibility to
isolate NP conjugates bearing three or more antibodies with the aim to determine
the maximal number of accessible targeting ligands on each individual NP.
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Therefore, a batch of NPs containing three PEG ligands (5NP-3P) was prepared
and isolated according to the same procedure as used for 5NP-1P and 5NP-2P
by increasing the EDC/NP ratio in the reaction mixture. Fluorescence spectra
were recorded using a Fluoromax-4P spectroﬂuorimeter from Horiba Scientiﬁc
(NJ, USA). Samples were excited at a ﬁxed wavelength (lex¼ 663 nm) and spectra
were recorded in a wavelength range between 673 and 800 nm. The ﬂuorescence
emission of ﬂuorescently labelled Tz (Tz-Alexa660) was detected at 690 nm. The slit
widths (for controlling magnitude and resolution of transmitted light) were
standardized at 5 and 5 nm for excitation and emission wavelength, respectively.
The data are shown in Fig. 2b. Fluorescence rises on attaching two instead of one
Tz per NP, thus demonstrating the different amount of Tz for the 5NP-1Tz and
5NP-2Tz conjugates. However, the conjugation with three molecules of Tz was not
possible as resulted from the comparison of the ﬂuorescent intensity of 5NP-1Tz,
5NP-2Tz and 5NP-3Tz, measured after reacting 5NP-1P, 5NP-2P and 5NP-3P,
respectively, with dye-labelled Tz (Fig. 2b). Indeed, the FI of 5NP-3Tz was
essentially the same as that of 5NP-2Tz, suggesting a saturation of the NP surface
area right after the introduction of two antibodies.
NP incubation with biological ﬂuid. A unit of 4.6 pmol of each functionalized
NP solution was incubated in 1ml of a 0.4mgml–1 fetal bovine serum (FBS)
solution for 5 and 48 h at 4 C under shaking. After incubation time both solutions
were centrifuged at 5,500g for 15min at 4 C to precipitate the NP-hard corona
complex34, and supernatants were removed using a syringe. Precipitates were
resuspended in PBS buffer (pH 7.2).
Identiﬁcation of the protein corona by SDS–PAGE. Functionalized NP-hard
corona complexes obtained as explained above were added to loading buffer
(62.5mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% glycerol, 0.04M dithiothreitol
and 0.01% (w/v) bromophenol blue) in PBS and heated at 100 C for 10min.
Samples were loaded on SDS–PAGE35 carried out in a Mighty Small apparatus
(Hoefer Scientiﬁc Instruments, San Francisco, CA) with an 8% acrylamide running
gel and a 4% stacking gel, 90min at 25mA. Proteins were revealed by Imperial
Protein Stain (Thermo Scientiﬁc). Data are shown in Supplementary Fig. 5.
BSA labelling using FITC. To further evaluate the effect of the immobilization of
different number of ligands on the NP surface, the amount of protein corona after
incubation of 5NP-1Tz and 5NP-2Tz with BSA was examined. For this purpose,
ﬁrst BSA had to be labelled with FITC. A volume of 0.2ml of 25mM FITC was
added to 0.2 nmol of BSA (Sigma-Aldrich) dissolved in 0.8ml of 0.1M NaHCO3,
pH 8.35. The reaction solution was vigorously stirred at room temperature for 2 h.
To eliminate FITC excess, the solution was loaded onto a PD10 column.
Afterwards different samples including different concentrations of BSA-FITC were
prepared to obtain a calibration curve. Fluorescence spectra were recorded using a
Fluoromax-4P spectroﬂuorometer. Samples were excited at a ﬁxed wavelength
(lex¼ 488 nm) and spectra were recorded in a wavelength window between 498
and 700 nm. The ﬂuorescence emission of BSA-FITC was detected at 518 nm.
The slit widths (for controlling magnitude and resolution of transmitted light)
were standardized at 5 nm for both excitation and emission wavelength.
Incubation of functionalized NPs with BSA-FITC and quantiﬁcation of
BSA-FITC corona by ﬂuorescence assay. A unit of 4.6 pmol of each functionalized
NP (5NP-1Tz and 5NP-2Tz) were incubated in 1ml of a 0.4mgml–1 BSA-FITC
solution for 5 and 48 h at 4 C under shaking. After incubation time, both solutions
were centrifuged at 5,500g for 15min at 4 C to precipitate NP-BSA-FITC corona
complex, and supernatants were removed using a syringe. Precipitates were
resuspended in PBS buffer (pH 7.2) and analysed with a spectroﬂuorometer. As
expected, the surface functionalization decreased the extent of protein adsorption
as it results from the measurements of FI, which, in the case of 5NP-1Tz, was
twofold higher than 5NP-2Tz (Supplementary Fig. 6). In this way, the results
conﬁrm a double-accessible surface area in 5NP-1Tz compared with 5NP-2Tz due
to the different extent of functionalization.
NP incubation with biological ﬂuid and DLS analysis of stability. A unit of
4.6 pmol of one or two Ab-functionalized NPs solution was incubated in 1ml of a
0.4mgml–1 FBS solution up to 96 h at 4 C under shaking. At 5, 24, 48, 96 h of
incubation both solutions were analysed by DLS.
Fluorescence quenching experiments. To determine if the ﬂuorescence of the NPs
can be altered in vivo, 5NP-1P, 5NP-2P, 5NP-1Tz and 5NP-2Tz were incubated
with human plasma at the same concentration. A volume of 50 ml of 0.1mgml 1
of all the samples were diluted in 200ml of human plasma (obtained with consensus
from 35 old male). Aliquots of 50 ml were taken at times 1, 2, 8, 24 and 48 h. The
ﬂuorescence was recorded at different time points exciting at 490 nm. The emission
at 515 nm was represented for all the samples and time points (Supplementary
Fig. 19). The emission of 5NP-1P and 5NP-2P can be neglected, as it is comparable
to the emission collected just using the plasma as sample (Supplementary Table 3).
Fluorescence of 5NP-1Tz and 5NP-2Tz remains constant along time with
variations of a 10% as maximum, as it is shown in the normalized data
(Supplementary Table 4). Remarkably, the presence of one or two antibodies can be
conﬁrmed in all the cases based on the ﬂuorescence (Supplementary Table 3), that
is, 5NP-2Tz has the double ﬂuorescence than 5NP-1Tz.
Cell cultures. JMT-1 was purchased by AddexBio (San Diego, CA), while the other
cell lines were purchased by American Type Culture Collection. MCF-7, MDA-MB
453 and MDA-MB 468 cells were cultured in 50% Dulbecco’s modiﬁed Eagle’s
medium (DMEM) high glucose and 50% Ham’s F-12 nutrient mixture,
supplemented with 10% FBS, L-glutamine (2mM), penicillin (50UIml–1) and
streptomycin (50mgml–1), while BT474 and SKBR3 cells were cultured in RPMI
1640 medium, supplemented with 10% FBS, L-glutamine (2mM), penicillin
(50UIml–1) and streptomycin (50mgml–1). MDA-MB 231 cells were cultured
in MEM Medium, supplemented with 10% FBS, L-glutamine (2mM), penicillin
(50UIml–1) and streptomycin (50mgml–1), while JIMT-1 were cultured in
DMEM medium, supplemented with 10% FBS, L-glutamine (2mM), penicillin
(50UIml–1) and streptomycin (50mgml–1). All cell lines were tested grow at 37 C
and 5% CO2 in a humidiﬁed atmosphere and were subcultured before conﬂuence
using trypsin/EDTA. Cell culture medium and chemicals were purchased from
EuroClone (Italy).
HER2 expression. MDA-MB 231, JIMT-1, MCF-7, MDA-MB 453, SKBR3, BT474
and MDA-MB 468 cells (5 105) were immunodecorated in ﬂuorescence-activated
cell sorting tubes with Tz (Herceptin, Roche, 1 mg per tube in PBS, 2% BSA and 2%
goat serum) for 30min at room temperature. Then, cells were washed thrice with
PBS and immunodecorated with Alexa Fluor 488 goat anti-human secondary
antibody (1ml per tube in PBS, 2% BSA and 2% goat serum) for 30min at room
temperature. After three washes with PBS cells were analysed by Cytoﬂex ﬂow
cytometer (Beckman Coulter). In all, 10,000 events were acquired for each analysis,
after gating on viable cells. A sample of cells immunodecorated only with
secondary antibody was used to set the region of positivity.
Cell-binding assay. MCF-7, BT474 and MDA-MB 468 cells were seeded day
before at a concentration of 3 105 cells per well. Then, cells were incubated 1 h at
37 C in culture medium supplemented with 13 and 65 nM FITC-labelled 5NP-1Tz
and 5NP-2Tz. FITC-labelled 5NP-1IgG and 5NP-2IgG or 5NP-1 and 5NP-2 were
used as speciﬁcity controls. After incubation, cells were washed three times with
PBS. Labelled cells were resuspended in 0.5ml of PBS and analysed by Cytoﬂex
ﬂow cytometer (Beckman Coulter). A total of 10,000 events were acquired for each
analysis, after gating on viable cells and on singlets. A sample of untreated cells was
used to set the appropriate gates.
Confocal laser scanning microscopy and immunoﬂuorescence. To assess
co-localization with different intracellular markers, MCF-7 cells were cultured on
collagen pre-coated coverglass slides, until sub-conﬂuence and were incubated 1
and 4 h at 37 C with 65 nM of NP-1Tz and NP-2Tz. Then, cells were washed twice
with PBS, ﬁxed for 10min with 4% paraformaldehyde and treated for immuno-
ﬂuorescence. After ﬁxation with 4% paraformaldehyde, cells were washed with PBS
and then treated for 5min with 0.1% Triton X-100. A blocking step was performed
for 1 h at room temperature with a solution containing 2% BSA, 2% goat serum
and 0.2 mgml 1 DAPI (40 ,6-diamino-2-phenylindole) in PBS. Golgi apparatus,
lysosomes, early endosomes and recycling endosomes were stained, respectively,
with Golgi Marker-130 (GM-130; cod. 610823, 1:100 dilution; clone 35; BD
Biosciences), antibodies against cathepsin D (CatD; cod. IM03-100 mg 1:50; clone
BC011; Millipore), early endosome antigen-1 (EEA1; cod. 610457; 1:1,000; clone
14; BD Biosciences) and transferrin (Tf; ab114008; 1:100; clone 5G2; Abcam) by
incubating 2 h at room temperature and revealed by a Alexa Fluor 546-conjugated
antibody against murine IgGs (A-11030; Invitrogen) at a 1:300 dilution by
incubating for 2 h at room temperature in PBS, 2% BSA and 2% goat serum.
Cells were mounted in Prolong Gold antifade reagent (Molecular Probes). All
chemicals used in the preparation of samples for confocal microscopy were
purchased from Sigma-Aldrich (Milano, Italy), except for DAPI, and the primary
and secondary antibodies purchased from Life Technologies Italia (Monza, Italy).
Microscopy analyses of stained cells were then performed with a Leica TCS SPE
confocal microscope (Leica Microsystems, Wetzlar, Germany) at Fondazione
Filarete, Milano, Italy. Images were acquired at 1,024 1,024 pixel resolution and
with a  63 or a  40 magniﬁcation oil-immersion lens for cells or sections,
respectively. Confocal microscopy images were analysed with Image J to calculate
Pearson coefﬁcient values with the JaCoP plugin.
Cell viability assay. MCF-7 cells were cultured on a 96-multi-well dish at the
density of 5,000 cells per square cm. Then, cells were incubated with different
amounts of 5NP-1Tz and 5NP-2Tz (13 and 65 nM). Untreated cells and Tz-treated
cells (13 and 65 nM) were used as controls. At the indicated time points (24, 48 and
72 h), cells were washed with PBS and then incubated for 3 h at 37 C with 0.1ml of
3-(4,5-dimethyl-2-thiazolyl)- 2,5-diphenyl-2H-tetrazolium bromide (MTT) stock
solution previously diluted 1:10 in DMEM medium without phenol red. After
incubation, MTT solubilizing solution (0.1ml) was added to each well to solubilize
the MTT formazan crystals (Promega). Absorbance was read immediately in a
microplate reader (BioTek) using a testing wavelength of 570 nm and a reference
wavelength of 620 nm. The results are normalized on viability of untreated samples
and expressed as means±s.e. of six individual experiments.
Cell death assay. MCF-7 cells were cultured on a 12-multi-well dish until
sub-conﬂuence. Then, cells were incubated 3 and 24 h at 37 C in the presence of
different amounts of 5NP-1Tz and 5NP-2Tz (13 and 65 nM). Untreated and
Tz-treated cells (13 and 65 nM) were used as controls. After incubation, cells were
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washed twice with PBS and treated for ﬂuorescence-activated cell sorting analysis
according to the Annexin V-PE-Cy5 Apoptosis Detection Kit manufacturer’s
protocol (BioVision). Brieﬂy, cells were resuspended in Binding Buffer and
incubated for 5min in presence of 5 ml of Annexin V-PE-Cy5. Cells were analysed
within 1 h on a Cytoﬂex ﬂow cytometer (Beckman Coulter). In all, 20,000 events
were acquired for each analysis, after gating on viable cells. For evaluation of late
apoptosis, the same protocol was used but incubation with 7- aminoactinomycin D
(BD Biosciences; 51-68981E; 5 ml per sample) was accomplished.
Production of xenograft tumour models. All animal experiments were conducted
under an approved protocol of the Italian Ministry of Health. Animals were cared
according to the guidelines of the Italian Ministry of Health and in the total respect
of EU guidelines for the animal welfare. MCF-7 cells, grown as described above,
were injected in 8-week-old female Balb/c nude mice after insertion on the neck of
oestrogen pellets (Innovative Research of America, USA) by using a trocar. All
tumour injections were done 2 days after pellet placing. MCF-7 (107 cells for each
animal) were suspended in growth medium and mixed with Matrigel high factor
(Sacco Srl, Italy) in 3:1 ratio and injected into mammary fat pad of mice. Animals
were observed and tumour formation was recorded at least three times per week.
Tumours were allowed to grow up to 8mm in diameter before mice treatment.
Measurement of NP gold in mice plasma. 5NP-1Tz or 5NP-2Tz (18 pmol per g
body weight), or 12NP or 20NP (3mg g 1) were injected in the tail vein of mice,
and retro-orbital blood collection was performed at 5, 24, 48 and 96 h post
injection. Collected blood was immediately added to heparin (Enoxaparin sodium
8000 IU anti-Xa activity) in a ratio 4:1 and then centrifuged (10min at 3,000g).
Plasma was then recovered and stored at –20 C.
Tumour targeting. AF660-labelled NP-Tz conjugates (18 pmol per g body weight)
or Tz (18 pmol per g body weight), or 12NP or 20NP (3 mg g 1) were injected in
the tail vein of mice and Epf imaging was performed at 5, 24, 48, and 96 h post
injection by placing the animals, anaesthetized by intraperitoneal injection
of 20mgml–1 of Avertin, in an IVIS Lumina II ﬂuorescence imaging system
(Calipers Life Sciences, UK) at 37 C. Images were acquired with a Cy5 emission
ﬁlter while excitation was scanned from 570 to 640 nm, and mice autoﬂuorescence
was removed by spectral unmixing. After in vivo acquisitions, mice were killed, and
dissected tumours were analysed in the IVIS system as described above for the
whole animals. All Epf values of tumour ROI and of the isolated tissues were
normalized to the Epf obtained by IVIS acquisition of the injected solutions in a
96-well plate ( 104), using the same acquisition parameters. The FI of tumour
homogenates was also measured. According to the procedure, the isolated tissues
were weighted and homogenized with ultraturrax in a homogenization buffer
(0.32M sucrose, 100mM HEPES, pH 7.4). Protein concentration of the samples
was measured using the bicinchonic acid (Pierce, CA) protein assay, while
ﬂuorescence was analysed in a GloMax Multi Detection System (Promega). The
ﬂuorescence values of all homogenates were normalized on the FI of the injected
solutions ( 105) as measured using the same spectroﬂuorimetric parameters.
Immunohistochemistry of ex vivo specimens. The 3 mm sections from formalin-
ﬁxed and parafﬁn-embedded tissues were cut, deparafﬁnized in xylene and
rehydrated in ethanol. Immunohistochemistry was performed, after microwave
oven pretreatment (pH 8.0, EDTA buffer, 2 50min), by using a polyclonal
antibody rabbit anti-653 human c-erb-2 oncoprotein (1:1,000 dilution, DakoCy-
tomation, 2 h incubation). The reaction was revealed by means of supersensitive
non-biotin detection system (BioGenex) and diaminobenzidine as chromogen. To
quantify c-erb-2 expression, a semiquantitative score based on the extension and
intensity of immunohistochemical staining was applied (score from 0 to 3þ ).
Data were analysed by GraphPad Prism software.
Confocal laser scanning microscopy and immunoﬂuorescence. To assess the
co-localization of nanoconjugates with different intracellular markers, MCF-7 cells
were cultured on collagen pre-coated coverglass slides, until sub-conﬂuence and
were incubated 1 and 4 h at 37 C with 65 nM of NP-1Tz and NP-2Tz. Then, cells
were washed twice with PBS, ﬁxed for 10min with 4% paraformaldehyde and
treated for immunoﬂuorescence. After ﬁxation with 4% paraformaldehyde, cells
were washed with PBS and then treated for 5min with 0.1% Triton X-100.
A blocking step was performed for 1 h at room temperature with a solution
containing 2% BSA, 2% goat serum and 0.2 mgml 1 DAPI in PBS. Golgi appa-
ratus, lysosomes, early endosomes and recycling endosomes were stained, respec-
tively, with Golgi Marker-130 (GM-130; cod. 610823, 1:100 dilution; clone 35; BD
Biosciences), antibodies against cathepsin D (CatD; cod. IM03-100 mg 1:50; clone
BC011; Millipore), early endosome antigen-1 (EEA1; cod. 610457; 1:1,000; clone
14; BD Biosciences), Tf (ab114008; 1:100; clone 5G2; Abcam) by incubating 2 h at
room temperature and revealed by a Alexa Fluor 546-conjugated antibody against
murine IgGs (A-11030; Invitrogen) at a 1:300 dilution by incubating for 2 h at
room temperature in PBS, 2% BSA and 2% goat serum. Cells were mounted
in Prolong Gold antifade reagent (Molecular Probes). All chemicals used in
the preparation of samples for confocal microscopy were purchased from
Sigma-Aldrich (Milano, Italy), except for DAPI, and the primary and secondary
antibodies purchased from Life Technologies Italia (Monza, Italy).
For the confocal microscopy of cryosections, MCF-7 tumours were isolated and
ﬁxed in 4% paraformaldehyde solution for 3 h, washed in PBS and embedded in
frozen tissue matrix (OCT) for freezing in liquid nitrogen. The 10 mm-thick tumour
cryosections were air-dried at room temperature for 1 h, rinsed with PBS and
treated for immunoﬂuorescence. For the immunodecoration of HER2 and
cytokeratin19, tumour cryosections were permeabilized with 0.1% Triton X-100 in
PBS for 5min. A blocking step was then performed for 1 h at room temperature
with a solution containing 2% BSA and 2% goat serum in PBS. Then, we performed
a 2 h incubation with the same rabbit anti-human c-erb-2 used for the
immunohistochemistry (dilution 1:1,000) or with a polyclonal antibody rabbit
anti- cytokeratin19 (Abcam; dilution to 5 mml 1). After three times washing with
PBS, the primary antibody was revealed by an Alexa Fluor 488-conjugated
antibody against rabbit IgGs at a 1:300 dilution, in a 2% BSA, 2% goat serum
solution and DAPI (1:1500) for 2 h at room temperature.
Microscopy analyses of stained cells and cryosections were then performed with
a Leica TCS SPE confocal microscope (Leica Microsystems, Wetzlar, Germany) at
Fondazione Filarete, Milano, Italy. Images were acquired at 1,024 1,024 pixel
resolution and with a  63 or a  40 magniﬁcation oil-immersion lens for cells or
sections, respectively. Confocal microscopy images of cultured cells were analysed
with Image-J to calculate Pearson coefﬁcient values with the JaCoP plugin.
TEM of ex vivo specimens. TEM analyses of NPs were performed by means of a
transmission electron microscope (Zeiss EM109), prepared by slow evaporation of
one drop of aqueous solution of the NPs placed on a formvar/carbon-coated
copper mesh grid and air-dried. For ex vivo analyses, small portions of MCF-7
tumour samples were ﬁxed in 2.5% glutaraldehyde in 0.1M phosphate buffer,
pH 7.2, for 2 h. After one rinsing with phosphate buffer, specimens were post-ﬁxed
in 1.5% osmium tetroxide for 2 h, dehydrated by 70, 90 and 100% ethanol, and
embedded in epoxy resin (PolyBed 812 Polysciences Inc., USA). Ultrathin sections
were examined by the Zeiss EM109 microscope.
Quantiﬁcation of gold in plasma by ICP-MS. ICP-MS analysis to determine the
amount of Au found in the different organs of mice after injection of Au NPs was
carried out similar to previous reports20. Before the measurement took place,
the ICP-MS set-up was calibrated with a freshly prepared serial dilution of gold
(Roth, Au-Standard (1,000mgml 1). The used calibration curve was constructed
using gold concentrations from 10 p.p.b. (parts per billion) to 2,500 p.p.b. In
addition, the auto-tuning solution from Agilent for ICP-MS 7500cs with a standard
concentration of 1 mg l 1 of Ce, Co, Li, Mg, Tl and Y was used to set the general
background, as well as to calibrate the electrical ﬁeld of the lenses and the
quadrupole ﬁeld in strength and frequency. Also accounted for were oxidation of
the ionized species during the tuning as well as double charge occurrences. In the
so calibrated set-up, the oxidation species rate was lower than 1.0% and double
charge rate was below 2%. All vials and working materials were either cleaned using
freshly prepared aqua regia for 2 h followed by boiling in Milli-Q water, or were
sterile and clean non-reusable consumables. The samples were introduced into the
ICP-MS set-up through a perﬂuoroalkoxy-alkane-based microﬂow spray chamber,
where the aqueous sample was nebulized, introduced into the argon gas ﬂow
and transported to the torch, where it was ionized in an argon plasma of around
6,000 C. After ionization, the sample was presorted using an omega lens, element-
wise separated in a quadrupole ﬁeld through the mass to charge rate, again sorted
using kinetic barriers and a charged lens system, and ﬁnally detected with either an
analogue or a digital detector depending on the count rate.
The extracted mouse organs with a weighted mass of mOrgan were dissolved
before measurement using 67wt% HNO3 with a volume VHNO3¼ 2ml (Fisher
Chemical, #7697-37-2) per organ for 48 h under constant agitation at room
temperature. From the solution containing the digested organ in HNO3,
200 ml were taken for analysis, mixed with 400 ml 37 wt% HCl (Fisher Chemical,
#7647-01-0), that is, diluted by a factor 3, to enhance the digestion of the
incorporated Au NPs and prepare for the ionization process during the plasma
interaction. This solution was again diluted by a factor of 10 with 2 wt% HCl after
2 h of digestion to protect the ICP-MS set-up from the aqua regia, resulting in an
overall dilution factor adil¼ 30. This diluted solution was then measured three
consecutive times to determine the mass concentration C0Au of elemental gold in
solution. C0Au (mg l 1) describes the solutions concentration. mg/L is also referred
to as p.p.b. (or 1 mg kg 1 (solution)¼ 10 9 g g 1 (solution)), as the density of all
used solutions is equal to the one of water¼ 1 kg l 1. DC0Au (%) describes the s.d.
between the three measurements. Thus, the concentration in the original solution
with the digested organ was calculated to CAu (p.p.b.)¼C0Au  adil (in a previous
work20 the results were presented as CAu/mOrgan (p.p.b. g 1), whereby the scaling
factor to mAu/mOrgan was VHNO3). The total mass of gold in each organ was calcu-
lated as mAu (g)¼CAu VHNO3. Thus, the mass of gold per mass of organ is mAu/
mOrgan. Data are provided in Supplementary Table 6 and Supplementary Fig. 9.
HER2 expression in ex vivo specimens. HER2 expression in MCF-7 tumour
lysates was assessed after isolation at 5, 24, 48 or 96 h of exposure to 5NP-Tz,
5NP-2Tz or free Tz (Supplementary Fig. 16). Tumours were lysed in SDS–PAGE
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application buffer, electrophoresed and immunoblotted using anti-HER-2
antibody. Calnexin expression was assessed as control. Uncropped scan of the
original immunoblot is reported in Supplementary Fig. 17.
Data availability. The authors declare that the data supporting the ﬁndings
of this study are available within the paper and its Supplementary Information
ﬁles.
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